What are the fundraising trends in the AI lab market?
In our updated market reports, you will find everything you need
SUMMARY
We analyzed publicly disclosed equity rounds raised by pure-play AI lab market companies between January 2024 and early July 2026. The tracker includes companies where more than 80% of the business is tied to AI research, model development, model experimentation, model evaluation, AI safety, model deployment infrastructure, training infrastructure, or AI research operations.
The AI lab market is absorbing far more capital over time. Full-year funding rose from about $30.2B in 2024 to about $89.1B in 2025, then surged to about $255.9B in year-to-date 2026 alone.
This is not a normal venture market. Capital is being allocated to a small number of strategic AI control points, especially frontier AI labs. In year-to-date 2026, the top 3 rounds captured about 84.8% of all capital.
Deal count is also increasing in the freshest period, but round size is doing most of the work. The AI lab market had 21 deals in year-to-date 2026 versus 14 over the comparable period in 2025, while capital rose from about $66.0B to about $255.9B.
AI Research Labs dominate the market by dollars. They captured about 76.5% of capital in 2024, 73.6% in 2025, and 94.1% in year-to-date 2026, even though they never represented a majority of deals.
Later-stage capital still overwhelms the AI lab market. In full-year 2025, late-stage and Series B-plus rounds captured about 96.7% of capital. In year-to-date 2026, Series D+ alone captured more than 92% of capital.
New AI lab startups are still entering the market, but they are not the main destination for dollars. First financings represented about 28.6% of deals in year-to-date 2026, but only about 5.4% of capital.
North America is becoming more dominant, not less. It captured about 94.5% of capital in 2024, 96.4% in 2025, and 98.8% in year-to-date 2026.
Evaluation Tooling is gaining credibility by deal activity, not capital share. The category rose from $98M in 2024 to about $203M in 2025 and $255M in year-to-date 2026, but it remains tiny compared with frontier-lab financing.
The central interpretation is that the AI lab market is splitting into two different markets: sovereign-scale model and compute companies on one side, and much smaller software, evaluation, safety, experimentation, and infrastructure tooling companies on the other.
Is more or less capital going into the AI lab market?
More capital is going into the AI lab market, and the increase is enormous. Full-year funding rose from about $30.2B in 2024 to about $89.1B in 2025, and year-to-date 2026 reached about $255.9B by early July.
The freshest comparison is even more striking. From January through early July 2026, AI lab market funding reached about $255.9B, compared with about $66.0B over the comparable period in 2025. That means capital is not just rising; it is accelerating sharply.
The caution is that this market is heavily distorted by giant rounds. In year-to-date 2026, the largest deal represented about 47.7% of all capital, and the top 3 deals represented about 84.8%. So the headline increase should not be read as every AI lab company suddenly raising more money.
The better interpretation is that the largest AI lab market companies are becoming strategic balance-sheet assets. OpenAI, Anthropic, xAI, and a small group of model-development and infrastructure companies are absorbing capital at a scale that looks closer to industrial infrastructure finance than ordinary venture capital.
So, more capital is clearly entering the AI lab market. But the capital is not spreading evenly. The increase is mostly a story about frontier AI labs and a few strategic control points raising vastly larger rounds.
Is AI lab funding activity driven by more deals or larger rounds?
AI lab funding activity is driven much more by larger rounds than by more deals. The clean full-year comparison shows capital rising from about $30.2B in 2024 to about $89.1B in 2025, while deal count fell from 32 to 28.
That is the key signal. A market cannot nearly triple in capital while deal count declines unless round size is doing most of the work. Average round size rose from about $942M in 2024 to about $3.18B in 2025.
The year-to-date comparison adds nuance because deal count is also up in 2026. From January through early July 2026, the AI lab market had 21 deals, compared with 14 over the same period in 2025. But capital rose nearly 4x, from about $66.0B to about $255.9B, so bigger rounds still explain most of the increase.
The median round also rose from about $202.5M over the comparable 2025 period to about $480M in year-to-date 2026. That means the visible funding floor moved upward, not only the top outlier.
The practical interpretation is simple: the AI lab market is not just getting busier. It is becoming structurally more capital-intensive. More deals matter, but larger rounds are the real driver.
Is AI lab capital moving toward later-stage or earlier-stage companies?
AI lab capital is still moving overwhelmingly toward later-stage companies, even though year-to-date 2026 shows a visible increase in large early-stage lab formation. In full-year 2025, late-stage and Series B-plus rounds captured about $86.2B, or 96.7% of total capital.
The same pattern is even more extreme in year-to-date 2026. Series D+ rounds alone captured about $237.0B, or more than 92% of all capital. That means the AI lab market’s dollar-weighted center of gravity is still firmly late-stage.
Early-stage activity is not dead. Seed and Series A rounds captured about $14.3B in year-to-date 2026, compared with about $756.5M over the comparable period in 2025. But that increase is heavily shaped by unusual rounds such as Prometheus, AMI Labs, and humans&.
The important point is that stage labels are becoming less informative in the AI lab market. A $12.0B Series A and a $1.03B seed round do not behave like normal early-stage venture financings. These are team-credential and strategic-thesis financings, not ordinary startup discovery rounds.
So capital is structurally later-stage, but the early-stage layer has become strange. Elite AI lab formation can now raise late-stage-sized capital at seed or Series A when the team, thesis, and strategic investor base are strong enough.
Is the AI lab market maturing or still experimental?
The AI lab market is maturing at the top and still experimental underneath. The top of the market looks mature because capital is concentrating around frontier labs, scaled model companies, and strategic infrastructure providers.
In full-year 2025, Growth Equity and Series D+ rounds together represented nearly 90% of all capital. In year-to-date 2026, Series D+ alone represented more than 92% of all capital. That is not an early experimental market at the top; it is a strategic scale-up market.
But the AI lab market is not mature across the whole stack. In year-to-date 2026, AI Experiment Platforms had only one qualifying deal, AI Safety Research had one, and Evaluation Tooling had four. Those categories are real, but they are still thin compared with the frontier-lab layer.
The best interpretation is bifurcation. Frontier AI labs are maturing into a strategic capital market shaped by hyperscalers, chip companies, sovereign funds, elite crossover investors, and infrastructure-linked financing. The tooling, safety, evaluation, and experimentation layers remain more experimental.
So the AI lab market is not simply mature or experimental. It is mature where model capability and compute control are already recognized as scarce strategic assets, and still experimental where the market is trying to define the software layers around those assets.
Are new startups still entering the AI lab market?
Yes, new startups are still entering the AI lab market, but new formation is not where most capital is going. In year-to-date 2026, first financings represented 6 of 21 deals, or about 28.6% of total deal activity.
That is a meaningful increase from the comparable period in 2025, when first financings represented about 14.3% of deals. New entrants such as humans&, Fundamental, AMI Labs, Autoscience, Prometheus, and Sail Research show that elite AI lab formation is still active.
But first financings captured only about 5.4% of year-to-date 2026 capital. The reason is simple: follow-on rounds for OpenAI, Anthropic, xAI, World Labs, and other already-visible companies were vastly larger.
The strongest reading is that new AI lab startups are still entering, but the bar for visibility is unusually high. The new companies that make it into the public funding record tend to have elite research teams, frontier-lab alumni, a world-model or physical-AI thesis, or infrastructure relevance to frontier model builders.
The AI lab market is therefore still producing new companies, but it is not an open, low-capital experimentation market. It is a market where new entrants need unusual credibility from day one.
Are more investors entering the AI lab market?
The evidence does not clearly show more investors entering the AI lab market. It shows much more capital being deployed by a relatively concentrated set of strategic and elite financial investors.
In full-year 2024, the AI lab market had approximately 153 unique disclosed investors. In full-year 2025, that figure fell to approximately 114, even though total capital rose from about $30.2B to about $89.1B.
The year-to-date comparison points in the same direction. From January through early July 2025, there were approximately 75 unique disclosed investors. Over the comparable period in 2026, there were approximately 73, even as capital rose from about $66.0B to about $255.9B.
That means the AI lab market is not expanding because a broad new crowd of investors is entering. The market is expanding because investors with strategic relevance, large balance sheets, compute access, or crossover capital capacity are writing much bigger checks.
The practical interpretation is that investor depth matters more than investor breadth. The AI lab market is becoming more capital-rich without becoming meaningfully more investor-diverse.
Are top investors getting more or less active in the AI lab market?
Top investors remain highly active in the AI lab market, but top-investor activity is shifting toward strategic infrastructure participation rather than ordinary venture deal frequency. NVIDIA is the clearest repeat signal, appearing in 9 disclosed deals in 2024, 8 in 2025, and 5 in year-to-date 2026.
In full-year 2025, Lightspeed also appeared in 8 deals, General Catalyst in 6, Andreessen Horowitz in 5, and Sequoia Capital in 4. That shows strong repeat activity among elite venture and strategic investors.
The year-to-date 2026 repeat-investor field is narrower. NVIDIA appeared in 5 deals, while Fidelity, MGX, Felicis, Emerson Collective, CRV, Dragoneer, and General Catalyst each appeared in 2. So the market still has repeat investors, but the repeat signal is increasingly concentrated around investors that can influence compute, distribution, or strategic credibility.
This is why investor identity matters more than raw investor count. One strategic investor participating in a $30B, $65B, or $122B round can matter more than several ordinary investors backing smaller software-tooling rounds.
The answer is that top investors are still active, but the meaning of activity has changed. In the AI lab market, the most valuable investors are not just those writing checks; they are the ones connected to compute, cloud distribution, enterprise demand, sovereign capital, or frontier AI ecosystems.
Which AI lab subcategories are gaining momentum?
The AI lab subcategories gaining momentum are AI Research Labs, Model Development Teams, Training Infrastructure, and Evaluation Tooling, but each is gaining momentum in a different way. AI Research Labs are gaining the most capital momentum by far.
AI Research Labs raised about $23.1B in 2024, about $65.6B in 2025, and about $240.8B in year-to-date 2026. That makes frontier lab financing the dominant growth engine of the AI lab market.
Model Development Teams are also gaining momentum in the freshest period. They raised about $2.3B in 2024 and about $2.6B in 2025, then reached about $13.3B in year-to-date 2026. That jump points to investor interest in specialized model frontiers such as world models, structured-data foundation models, and physical-world AI.
Training Infrastructure continues to gain, though less dramatically. The category raised about $2.2B in 2024, $3.5B in 2025, and about $1.5B in year-to-date 2026. The equity data probably understates the true compute-financing picture because debt, cloud commitments, chip supply, and hyperscaler capex sit outside the pure equity filter.
Evaluation Tooling is gaining credibility faster than capital share. The category rose from $98M in 2024 to about $203M in 2025 and $255M in year-to-date 2026. That suggests evaluation is becoming a required layer for AI builders, even if investors still fund it as software infrastructure rather than frontier-scale capital infrastructure.
Which AI lab subcategories are losing momentum?
The AI lab subcategories losing momentum are Research Operations Services, Model Deployment Platforms, and AI Safety Research, although each decline needs to be interpreted carefully. Research Operations Services looks like the sharpest reversal because it raised about $14.8B in 2025 and had no qualifying deal in year-to-date 2026.
That apparent reversal is heavily distorted by Scale AI’s $14.3B Meta transaction in 2025. Without another Scale-sized strategic transaction, Research Operations Services naturally looks weaker, even if expert-data and research operations remain important to AI lab workflows.
Model Deployment Platforms also look weaker. The category raised $398M in 2024, $300M in 2025, and had no qualifying year-to-date 2026 deal in the supplied evidence. That does not mean deployment is unimportant; it means deployment tooling is not where the biggest equity checks are going.
AI Safety Research is more volatile than structurally weak. The category looked large in 2024 and 2025 because Safe Superintelligence raised unusually large rounds. In year-to-date 2026, the category had only one qualifying deal, Straiker’s $64M Series A.
The better interpretation is that these categories remain necessary but are not setting the capital agenda. The AI lab market’s largest checks are moving toward model ownership, compute access, and strategic model-development theses, while safety, deployment, and research operations are funded as smaller enabling layers.
Which regions are gaining momentum in the AI lab market?
North America is gaining the most momentum in the AI lab market. North America captured about $28.5B in 2024, about $85.9B in 2025, and about $252.8B in year-to-date 2026.
This is not just a dollar story. North America represented about 78.1% of deals in 2024, 89.3% in 2025, and 85.7% in year-to-date 2026. So North America is winning both by capital and by visible deal activity.
Asia-Pacific is also showing some momentum in year-to-date 2026, but from a much smaller base. It had about $2.0B across two qualifying deals, Moonshot AI and Deccan AI, after having no qualifying capital in the comparable 2025 period.
Europe’s position is more mixed. Europe produced meaningful full-year 2025 rounds through Mistral AI and Nscale, totaling about $3.1B. But in year-to-date 2026, Europe’s activity was concentrated in one deal, AMI Labs’ $1.03B seed round.
The strongest regional conclusion is that North America is gaining the most momentum, Asia-Pacific is showing selective challenger signals, and Europe remains credible but narrow. The AI lab market is not globalizing evenly.
Which regions are losing momentum in the AI lab market?
Europe is the clearest region losing visible momentum in the freshest AI lab market comparison. Europe raised about $3.1B across two qualifying deals in full-year 2025, but only about $1.03B across one qualifying deal in year-to-date 2026.
That one European deal, AMI Labs, is strong on its own. But one billion-dollar seed round is not the same as a broad regional funding wave. Europe remains visible, but the evidence is narrow.
The Middle East is also losing momentum in the supplied evidence. It appeared in full-year 2025 through Decart’s $100M round, but had no qualifying deal in year-to-date 2026.
Latin America and Africa remain absent across the observed periods. They had no qualifying AI lab market deals in 2024, 2025, or year-to-date 2026 under the strict pure-player and authoritative-source screen.
The practical reading is that regional weakness outside North America should not be interpreted as no AI activity. It means that visible, disclosed, pure-play AI lab equity financing remains concentrated in a few geographies, and several regions are not yet producing rounds that meet this strict funding-tracker threshold.
Is the AI lab market becoming more global or more regionally concentrated?
The AI lab market is becoming more regionally concentrated, not more global, when measured by capital. North America captured about 94.5% of capital in 2024, 96.4% in 2025, and 98.8% in year-to-date 2026.
Deal count is less extreme but still concentrated. North America represented about 78.1% of deals in 2024, 89.3% in 2025, and 85.7% in year-to-date 2026.
This does not mean Europe and Asia-Pacific are irrelevant. Europe has Mistral AI, Nscale, and AMI Labs. Asia-Pacific has Sakana AI, Moonshot AI, and Deccan AI. These companies show that AI lab formation is technically global.
But technical ambition is not the same as financing power. Frontier-scale capital formation still clusters around North America’s hyperscalers, chip suppliers, crossover investors, sovereign-linked funds, and elite technical labor markets.
So the AI lab market is global in innovation nodes, but regionally concentrated in capital. The ability to raise at frontier scale remains overwhelmingly North American.
Is AI lab capital moving toward proven winners or new opportunities?
AI lab capital is moving decisively toward proven winners, while a smaller but strategically important stream still funds new opportunities. In full-year 2025, follow-on rounds captured about 97.5% of capital. In year-to-date 2026, follow-on rounds captured about 94.6%.
The clearest signal is repeated mega-financing of the same companies. OpenAI, Anthropic, and xAI raised massive rounds across the observed period. Anthropic raised twice in year-to-date 2026 alone, and the later round was larger than the earlier one.
New opportunities are still visible. First financings represented about 28.6% of year-to-date 2026 deals, including humans&, Fundamental, AMI Labs, Autoscience, Prometheus, and Sail Research.
But first financings captured only about 5.4% of year-to-date 2026 capital. Even that figure is heavily influenced by Prometheus’ $12.0B Series A; without that outlier, the first-financing share would be much smaller.
The best interpretation is that the AI lab market is a proven-winner market with selective elite new formation. Capital is not being spread broadly across unproven experiments; it is going first to already-recognized strategic assets, then to a small group of unusually credible new teams.
Is the AI lab market becoming winner-takes-most?
Yes, the AI lab market is becoming winner-takes-most. The top 3 deals captured about 61.7% of capital in 2024, 75.5% in 2025, and 84.8% in year-to-date 2026.
The bottom half of deals tells the same story from the other side. The bottom 50% of deals captured about 4.7% of capital in 2024, 1.6% in 2025, and only 0.43% in year-to-date 2026.
The ratio of the largest deal to the median deal also became more extreme. The largest round was about 27.5x the median in 2024, 122.1x in 2025, and 254.2x in year-to-date 2026.
This is not winner-takes-all. Evaluation tooling, safety, infrastructure, experimentation platforms, and specialized model companies are still getting funded. But the capital economy is dominated by a small number of frontier labs and strategic control points.
So the AI lab market is clearly winner-takes-most. The winners are not taking every deal, but they are taking almost all the dollars.
Is the next wave of AI lab winners becoming visible?
Yes, the next wave of AI lab winners is becoming visible, but it is visible through investor-quality, technical-thesis, and bottleneck-positioning signals rather than broad revenue proof. The most important emerging areas are specialized model development, world models, physical-world AI, evaluation, and AI-native infrastructure.
Prometheus, World Labs, Fundamental, AMI Labs, humans&, General Intuition, Sail Research, and LMArena are among the strongest next-wave signals in the year-to-date 2026 evidence. These companies are not identical, but they sit near bottlenecks that frontier AI builders care about.
The funding scale is notable. Prometheus raised $12.0B, World Labs raised $1.0B, AMI Labs raised $1.03B, humans& raised $480M, General Intuition raised $320M, and Fundamental raised $255M. These are not small option bets.
The caution is that large early rounds do not prove durable winners. They prove that investors believe the founding team, technical thesis, and market timing are credible enough to fund ahead of conventional traction.
The next wave of AI lab market winners is becoming visible, but not yet fully validated. The strongest candidates are those tied to world modeling, physical-world reasoning, structured-data models, agent infrastructure, model evaluation, or compute-efficient scaling.
Is the AI lab funding landscape fragmenting or consolidating?
The AI lab funding landscape is consolidating in capital terms while fragmenting in technical themes. Capital is consolidating because the top 3 deals captured about 61.7% of capital in 2024, 75.5% in 2025, and 84.8% in year-to-date 2026.
At the same time, the technical surface area is widening. The AI lab market now includes frontier labs, model-development teams, training infrastructure, evaluation tooling, safety, experiment platforms, research operations, and deployment platforms.
Year-to-date 2026 includes world models, physical-world engineering models, structured enterprise data models, AI-agent infrastructure, evaluation systems, AI security, and GPU infrastructure. That is technical fragmentation.
But most capital still flows to a few perceived control points. OpenAI, Anthropic, xAI, and a small set of model-development or infrastructure companies determine the market’s dollar-weighted direction.
The practical interpretation is that product theses are fragmenting, while funding power is consolidating. The AI lab market is becoming more technically diverse and more financially concentrated at the same time.
Where is investor attention shifting in the AI lab market?
Investor attention in the AI lab market is shifting toward frontier-scale model ownership, world-model and physical-world AI theses, AI-native infrastructure, and evaluation for agents. The clearest dollar shift remains toward AI Research Labs.
AI Research Labs raised about $23.1B in 2024, $65.6B in 2025, and $240.8B in year-to-date 2026. That confirms that investors still prioritize companies that can own or shape frontier model capability.
The more interesting shift is happening below the largest labs. Model Development Teams raised about $13.3B in year-to-date 2026, driven by specialized theses around world models, physical-world AI, structured enterprise data, and artificial general engineering.
Evaluation Tooling is also attracting more attention, even though it remains small in capital terms. The category raised $98M in 2024, about $203M in 2025, and $255M in year-to-date 2026. That points to rising demand for benchmarking, monitoring, stress-testing, and governing increasingly agentic AI systems.
The strongest reading is that investor attention is shifting from “can this company build an AI model?” toward “can this company control a scarce AI bottleneck?” Those bottlenecks include frontier capability, compute access, world modeling, physical-world reasoning, agent reliability, evaluation infrastructure, and strategic data loops.
INSIGHTS
The insights below come from reviewing publicly disclosed equity funding rounds in the AI lab market between January 2024 and early July 2026, filtered for pure-play companies, disclosed round sizes, and authoritative source confirmation.
- The AI lab market should be interpreted as a strategic-capital market, not a normal venture market. Capital rose from about $30.2B in 2024 to $89.1B in 2025 and $255.9B in year-to-date 2026, while deal count moved much less dramatically.
- Capital concentration is increasing faster than market activity. The top 3 deals captured 61.7% of capital in 2024, 75.5% in 2025, and 84.8% in year-to-date 2026, which means headline funding totals are becoming more dependent on fewer companies.
- The average round size is becoming less representative over time. Average round size rose from $942M in 2024 to $3.18B in 2025 and $12.19B in year-to-date 2026, while the median moved more moderately from $240M to $327.5M to $480M.
- The bottom half of the AI lab market is becoming economically less relevant even though it remains strategically interesting. The bottom 50% of deals captured 4.7% of capital in 2024, 1.6% in 2025, and only 0.43% in year-to-date 2026.
- AI Research Labs are the dominant capital sink, not merely the largest category. They captured 76.5% of capital in 2024, 73.6% in 2025, and 94.1% in year-to-date 2026 without ever representing a majority of deal count.
- The AI lab market’s center of gravity is shifting from venture discovery to infrastructure-scale capitalization. Series D+ rounds represented more than 92% of year-to-date 2026 capital, which makes late-stage strategic scale the dollar-weighted story.
- First financings are more active in year-to-date 2026, but first-financing capital is still structurally secondary. First financings represented 28.6% of year-to-date 2026 deals, yet captured only 5.4% of capital.
- Stage labels are becoming less reliable in the AI lab market. A $12.0B Series A and a $1.03B seed round are not economically comparable to normal early-stage venture rounds, so company quality, team pedigree, and strategic relevance matter more than the stage name.
- Founder pedigree is functioning as a substitute for product evidence in new AI lab formation. The largest first financings are tied to elite researchers, frontier-lab alumni, or ambitious model theses rather than conventional go-to-market proof.
- The strongest validation signal is not only who invests, but whether the investor controls a scarce input. NVIDIA’s repeated presence matters because NVIDIA is linked directly to compute access, one of the binding constraints in the AI lab market.
- Strategic investors are becoming more important than purely financial investors. NVIDIA, Microsoft, Amazon, SoftBank, AMD, Cisco, MGX, sovereign funds, and hyperscalers are shaping access to compute, distribution, customers, and infrastructure.
- North America’s dominance is strengthening. North America captured 94.5% of capital in 2024, 96.4% in 2025, and 98.8% in year-to-date 2026, so the AI lab market is not becoming more geographically balanced by dollars.
- The AI lab market is global in technical ambition but not global in financing power. Europe and Asia-Pacific produce credible companies, but the ability to raise frontier-scale capital remains concentrated in North America.
- Evaluation Tooling is gaining credibility faster than capital share. Funding rose from $98M in 2024 to $203M in 2025 and $255M in year-to-date 2026, but the category remains tiny beside frontier-lab financing.
- The small capital share of Evaluation Tooling does not mean evaluation is unimportant. It means evaluation is currently funded as a software-scale enabling layer, not as a frontier-scale balance-sheet requirement.
- AI Safety Research is volatile because the category depends on a few unusual financings. Safe Superintelligence made the category look large in 2024 and 2025, while year-to-date 2026 looks much smaller without another SSI-scale event.
- Research Operations Services is similarly distorted by one large strategic transaction. Scale AI’s Meta investment made the category the second-largest in 2025, but the absence of a comparable year-to-date 2026 deal makes the category look weaker.
- Model Deployment Platforms appear underfunded relative to operational importance. The category raised $398M in 2024, $300M in 2025, and no qualifying capital in year-to-date 2026, suggesting investors do not currently view deployment tooling as the main value-capture layer.
- Training Infrastructure is gaining, but equity rounds do not capture the full compute-financing picture. Cloud commitments, debt, capex, chip supply, and hyperscaler agreements likely absorb a large amount of real AI infrastructure financing outside the pure equity dataset.
- The next wave of AI lab winners is most visible in specialized model-development theses. World models, physical-world AI, structured-data foundation models, and agent infrastructure are receiving large enough rounds to show serious investor conviction.
- The AI lab market is separating into two markets: sovereign-scale model and compute companies on one side, and smaller software, safety, evaluation, experimentation, and tooling companies on the other. Combining both without interpretation makes averages misleading.
- The most useful diligence rule is to discount generic AI-platform language unless it is paired with evidence of compute access, frontier talent, proprietary model capability, evaluation infrastructure, strategic data loops, or strategic investor participation.
OUR METHODOLOGY TO BUILD THIS TRACKER
We built this AI lab funding tracker by reviewing publicly disclosed equity rounds raised by pure-play AI lab market companies between January 2024 and early July 2026. A company counts as pure-play when more than 80% of its activity is dedicated to AI research, model development, model experimentation, model evaluation, AI safety, model deployment infrastructure, training infrastructure, or AI research operations.
We applied four core filters. First, we only included equity rounds or explicitly reported strategic equity investments. Second, we only counted rounds of $300K or more. Third, we only kept pure-play companies in the AI lab market, which excluded horizontal AI applications, vertical AI software, consumer AI search, legal AI, healthcare AI, sales and support AI, generic MLOps, debt-only financings, grants, acquisitions, and adjacent data-center deals not explicitly built for AI workloads. Fourth, every accepted entry had to be confirmed by a direct company announcement, a press release, a tier-1 media report, a specialized industry source, or a relevant regional publication.
Undisclosed-amount rounds were excluded because including them would distort dollar-based metrics such as total funding, average round size, category share, stage share, and concentration ratios. Rumored rounds, unclosed financing talks, secondary-only transactions without a clear primary financing component, and vague strategic partnerships were also excluded unless the source clearly reported equity-like fundraising.
The resulting tracker should be read as a public-source funding dataset, not a complete private-market database. Stealth rounds, unannounced SAFEs, private secondary transactions, confidential strategic investments, and undisclosed financings may exist outside the public record. The purpose of the tracker is to measure the visible, source-backed AI lab market using consistent inclusion rules across 2024, 2025, and year-to-date 2026.
Related blog posts
- Which startups have raised the most funding in the AI lab market?
